- 专利标题: NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES
-
申请号: US18399827申请日: 2023-12-29
-
公开(公告)号: US20240130774A1公开(公告)日: 2024-04-25
- 发明人: Bobak Robert Azamian , Jonathan Allen Coe , Scott Bradley Vafai
- 申请人: Medtronic Ireland Manufacturing Unlimited Company
- 申请人地址: IE Dublin 2
- 专利权人: Medtronic Ireland Manufacturing Unlimited Company
- 当前专利权人: Medtronic Ireland Manufacturing Unlimited Company
- 当前专利权人地址: IE Dublin 2
- 主分类号: A61B18/02
- IPC分类号: A61B18/02 ; A61B17/00 ; A61B17/32 ; A61B18/04 ; A61B18/06 ; A61B18/14 ; A61B18/18 ; A61B18/20 ; A61B18/24 ; A61K9/00 ; A61K31/045 ; A61K31/05 ; A61K31/395 ; A61K33/30 ; A61K45/06 ; A61M5/14 ; A61N1/05 ; A61N5/00 ; A61N7/00
摘要:
According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
公开/授权文献
- US1707876A Brake mechanism 公开/授权日:1929-04-02
信息查询